NCT01995383View on ClinicalTrials.gov

A Single Ascending Dose Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Atherosclerosis
Interventions
OTHER

LS followed by NS diet condition

LS diet period followed by NS diet period

OTHER

NS followed by LS diet condition

NS diet period followed by LS diet period

DRUG

Placebo

Single oral administrations

DRUG

Placebo

2 single oral administrations

DRUG

RO6836191

Orally administered, single ascending doses

DRUG

RO6836191

2 single oral doses

DRUG

RO6836191

Intravenous administration

Trial Locations (1)

08053

Marlton

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01995383 - A Single Ascending Dose Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Volunteers. | Biotech Hunter | Biotech Hunter